epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Bimzelx (bimekizumab-bkzx)
    bimekizumab
  • remove Focalin
    dexmethylphenidate hydrochloride
  • remove Imuldosa (ustekinumab-srlf)
    ustekinumab
  • remove Reglan
    metoclopramide

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Focalin (dexmethylphenidate hydrochloride) + Reglan (metoclopramide)

Monitor/Modify Tx


dexmethylphenidate + metoclopramide

monitor BP, serotonin syndrome sx, especially during initiation/titration: combo may incr. risk of serotonin syndrome, HTN (additive effects)

Caution Advised

Smiley face Smiley face Bimzelx (bimekizumab-bkzx) (bimekizumab) + Imuldosa (ustekinumab-srlf) (ustekinumab)

Caution Advised


bimekizumab + ustekinumab

caution advised: combo may incr. risk of serious infection (additive effects)

Additional Considerations

Smiley face Smiley face ustekinumab in Imuldosa (ustekinumab-srlf)

caution advised w/ narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx w/ immune modulators may reverse this effect, resulting in altered levels of concomitant drugs

Smiley face Smiley face dexmethylphenidate in Focalin

serdexmethylphenidate is the prodrug of dexmethylphenidate; similar interactions anticipated

add MAO inhibitor to Interaction Check if recent (14 days) use

Smiley face Smiley face bimekizumab in Bimzelx (bimekizumab-bkzx)

caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information